You are here:

Search

Site Search

Search results.

  • TREATS

    • TB and HIV are the leading infectious causes of death worldwide. For people living with HIV, TB is the most significant co-infection, 40 percent of HIV deaths in 2016 were due to TB. TB continues to disproportionately affect the most vulnerable individuals and communities. If…

    • The ‘universal test and treat’ approach – whereby people in high burden areas are actively offered TB and HIV testing and linkage to care – has been proposed by the public health community as a strategy to achieve steep reductions in HIV and TB.

      To encourage countries…

    • Colleen, 22, was diagnosed with TB through the TREATS study and is now on treatment. In Bloekombos, Cape Town, South Africa. Photo credit: Will Boase / The Union

    • TREATS is now measuring whether the PopART intervention was similarly successful in reducing the prevalence and incidence of TB in the same communities – whilst also raising awareness of TB and HIV through community engagement and linking anyone who tested positive for TB or…

  • Integrated HIV Care Programme - Myanmar

    Through its Integrated HIV Care (IHC) Programme, The Union Office in Myanmar currently provides services to nearly 34,000 People Living with HIV, more than 33,400 of which are taking antiretroviral treatment.

  • Community Advisory Panel (UCAP)

    The Union's Community Advisory Panel (UCAP) is a voluntary group of engaged members of affected communities and civil society who advise The Union’s board and management on how to best address the needs of affected communities and civil society across the organisation.…

  • Regional and Country Office Directors

  • Scientific Department Directors

  • TREAT TB

    Read more about TREAT TB (Technology, Research, Education and Technical Assistance for Tuberculosis), an ambitious initiative that was launched by The Union, seeking to contribute new knowledge regarding shorter, more tolerable treatment…

  • Community-Based MDR-TB Care Programme

    • Established in 2015, the Community-Based DR-TB Care Programme, partners with healthcare workers, nurses, and community volunteers to establish an extensive group of people equipped to provide drug-resistant tuberculosis (DR-TB) care and support services. It is implemented in…

  • Leadership

    • The Union's elected leadership is comprised of the Board of Directors, the Conference Scientific Committee, and the Community Advisory Panel (UCAP)

    • The Union's Management Team, headed up by the Executive Director, comprises the Heads of Managed Units, Scientific Departments and Country Offices, as well as a core team of Central Services.

    • Our members inform, support and help steer the organisation

  • Management Team

    • The Union's Management Team, headed up by the Executive Director, comprises the Heads of Managed Units, Scientific Departments and Country Offices, as well as a core team of Central Services.

  • Conference Scientific Committee

    The Conference Scientific Committee coordinates the development of the scientific programme of The Union World Conference on Lung Health. , Members have a two year terms.

  • Board of Directors

    • The Board Members are elected by the organisation's membership. It welcomes appointments from all races, colour, nationality or ethnic origin, gender, disability, marital status, age, religion or belief, sexual orientation or any other condition that cannot be justified.…

  • Journals

    • In order to share scientific research of immediate concern as rapidly as possible, The Union is fast-tracking the publication of certain accepted articles from the IJTLD and PHA and publishing them in full on our website, prior to their publication in the Journals. …

  • Union study supports shorter treatment for multidrug-resistant TB

    • Until recently, the World Health Organization (WHO) TB treatment guidelines recommended treatment regimens that lasted 20-24 months and required frequent injections, which posed a significant burden both for patients and for health systems tasked with administering treatment…

    • Given the duration and poor outcomes from the long MDR-TB treatment, The Union established he world’s first multi-country randomised clinical trial to test the efficacy, safety and economic impact of shortened MDR-TB treatment regimens, the Standardised Treatment Regimen of…

    • Victorien lives in Benin. He contracted TB at 18 years old, but after treatment, he was diagnosed with MDR-TB, at which point he was included in the nine-month study. He finished his treatment in 2013 and went on to studying a chemistry, biology, geology joint degree at…

    •  

      In parallel to the STREAM trial, The Union implemented an operational research study into the STREAM stage one, short course regimen in nine countries in francophone Africa.

      The study began in January 2013 and was concluded in 2016. The objectives were…

  • About The Union UPDATED

    The Union’s approach to tackling the above global problems is unique; we start with developing knowledge through global research (KNOW), which we then share as widely as possible (SHARE) and turn that into the real action that is needed to save lives on a local level (ACT).

  • Union welcomes EC authorisation of TB Alliance’s BPaL treatment for drug-resistant TB

    The Union welcomes today’s announcement that a new treatment developed by TB Alliance has been approved by the European Commission for some of the most drug-resistant forms of TB

  • On World Lung Cancer Day respiratory groups stress lung cancer risks and the importance of early screening and treatment

    In support of World Lung Cancer Day, FIRS, of which The Union is a founding member, calls for more awareness and understanding of lung cancer risk factors, as well as the importance of early screening and treatment

  • STOP, a global tobacco industry watchdog

    The Union’s Senior Program Manager for STOP

  • Black Lives Matter

    This month, The Union's Past President, Dr Jeremiah Chakaya Muhwa, writes a special feature about the Black Lives Matter movement.  

  • How to manage children if a second wave of COVID-19 occurs

    A letter to the editors of the IJTLD arguing that we should avoid restrictions on children’s lives during any new waves of COVID-19 – and avoid school closures.

  • Union article analyses impact of COVID-19 lockdown on TB incidence and mortality in India

    An article co-authored by The Union has estimated that 186,000 new tuberculosis (TB) cases and 88,000 additional TB deaths could be expected in India in 2020 as a consequence of the COVID-19 lockdown.

  • Public Health Action

    Public Health Action aims to disseminate the latest operational research on health systems, public health and disease control.

    We have recently expanded the scope of PHA to provide coverage of relevant areas of the UN's Sustainable…

  • Bloomberg Initiative to Reduce Tobacco Use Grants Program

    The Union has managed 495 Bloomberg tobacco control grants in 45 countries.

  • The latest issues of IJTLD OPEN

    • Read all issues of IJTLD OPEN for FREE. Click the title to access the open access PDF.
    • EDITORIAL

      Rethinking latent TB? Think again R.E. Chaisson, P.C. Hopewell 

      ORIGINAL ARTICLES

      Outcomes of people with TB reported to the WHO Global Clinical Platform of COVID-19 M. Bastard, et al.

      Yield of TB screening in prisons in Tajikistan S. Moe, et…

    • EDITORIAL

      Update on IJTLD OPEN: the future is open H.D. Blackbourn, G.B. Migliori 

      ORIGINAL ARTICLES

        A 10-year review of isoniazid-resistant TB management in Uzbekistan 2009-2020 M.L. Rekart, et al. Severe outcomes among adults with TB during COVID…

    • EDITORIAL

      Embracing novel thinking to safeguard against airborne pathogens in indoor spaces H. van der Westhuizen, et al.

      ORIGINAL ARTICLES

      Cost and cost-effectiveness of BPaL regimen used in drug-resistant TB treatment in the Philippines D. Evans, et al.  …

    • EDITORIAL

      Comprehensive care for people affected by TB: addressing TB-associated disabilities M. Calvi, et al. 

      ORIGINAL ARTICLES

      Disability, comorbidities and risk determinants at end of TB treatment in Kenya, Uganda, Zambia and Zimbabwe S.A. Adakun, et al.…

    • EDITORIAL

      A publicly accessible global data repository – the WHO TB-IPD platform R. L. Goodall, et al. 

      ORIGINAL ARTICLES

      A pilot cross-sectional study of non-communicable diseases in TB household contacts Y. Hamada, et al.  

      Characteristics of and…

    • EDITORIAL

      Guidelines for the diagnosis and management of post-TB lung disease: a call to action D.R. Silva, S. Inwentarz 

      VIEWPOINT

      Operational research as a mechanism to improve treatment outcomes for drug-resistant TB in the WHO European Region G.B. Migliori…

    • EDITORIAL

      Applying ‘timeliness’ to the screening and prevention of TB in household contacts of pulmonary TB patients A. D. Harries, et al.

      ORIGINAL ARTICLES

      A social enterprise model for TB detection and treatment through the private sector in Pakistan S. M. A.…

    • EDITORIALS

      Launch of IJTLD OPEN: a new home for open access papers on respiratory disease H. D. Blackbourn & G. B. Migliori Global reporting on TB in children and adolescents: how far have we come and what remains to be done? S. Verkuijl, et al. More is needed to…

  • PHA Plagiarism Policy

    • All articles submitted to PHA will be verified using the iTHENTICATE plagiarism detection software.

      A specific process is followed to deal with plagiarism, following the guidelines outlined in the Committee on Publication Ethics (COPE) flowcharts.

      For…

  • In memoriam: Dr Gulshan Rai Khatri

    Padma Shri Dr Gulshan Rai Khatri, a legendary figure on the front lines of India's fight against TB, sadly died earlier this month, aged 76.